SCHEMBL6497902

SCHEMBL6497902

NC(=O)Nc1cn(-c2cccc(-c3ccc(F)c(Cl)c3)c2)nc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.43
ITK Q08881 1/20 0.42
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 4/20 0.40
GRIN2B Q13224 3/20 0.40
MAPT P10636 2/20 0.40
ICMT O60725 2/20 0.40
LMNA P02545 2/20 0.40
GRIN1 Q05586 1/20 0.40
HPGD P15428 1/20 0.40
MDM2 Q00987 2/20 0.39
IRAK4 Q9NWZ3 2/20 0.39
PARP1 P09874 1/20 0.39
PARP2 Q9UGN5 1/20 0.39
PARP3 Q9Y6F1 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CHRNA7 P36544 1/20 0.39
HTT P42858 2/20 0.39
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6501636 0.90 SCN9A (0.45) SCN9AITKALDH1A1KDM4EMAPT
SCHEMBL6504832 0.90 GRIN2B (0.41) ITKALDH1A1KDM4EGRIN2BMAPT
SCHEMBL6498355 0.89 KDM4E (0.47) SCN9AITKALDH1A1KDM4EMAPT
SCHEMBL6499924 0.88 IKBKB (0.48) SCN9AITKALDH1A1KDM4EMAPT
SCHEMBL6501657 0.88 ITK (0.44) SCN9AITKALDH1A1KDM4EGRIN2B
SCHEMBL6506096 0.87 SCN9A (0.48) SCN9AITKALDH1A1KDM4EMAPT
SCHEMBL6508463 0.87 ITK (0.45) SCN9AITKALDH1A1KDM4EMAPT
SCHEMBL6502412 0.86 SCN9A (0.47) SCN9AITKALDH1A1KDM4EGRIN2B
SCHEMBL6502065 0.85 SCN9A (0.46) SCN9AITKALDH1A1KDM4EMAPT
SCHEMBL6507603 0.84 ITK (0.49) SCN9AITKALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 SCN9A 4159/4885ITK 4236/4885ALDH1A1 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.